{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:44:00Z","timestamp":1762854240864,"version":"build-2065373602"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.gofs.2020.12.010","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:30:23Z","timestamp":1609587023000},"page":"255-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survie globale et sans r\u00e9cidive locale en cas de radioth\u00e9rapie du lit tumoral des carcinomes canalaires in situ du sein\u00a0: revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"49","author":[{"given":"L.","family":"Kuntz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Le F\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mathelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Pivot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2020.12.010_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.breast.2012.01.014","article-title":"Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983\u20132007","volume":"21","author":"Puig-Vives","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.gofs.2020.12.010_bib2","first-page":"481","article-title":"Cancer statistics: breast cancer in situ","volume":"65","author":"Ward","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gofs.2020.12.010_bib3","article-title":"Ductal carcinoma in situ: a french national survey. Analysis of 2125\u00a0patients","author":"Cutuli","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.gofs.2020.12.010_bib4","first-page":"290","article-title":"Breast Cancer\u2013Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gofs.2020.12.010_bib5","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194\u00a0study","volume":"33","author":"Solin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamaoncol.2016.3031","article-title":"Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial","volume":"3","author":"Vrieling","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib7","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.canrad.2016.07.025","article-title":"Radioth\u00e9rapie du cancer du sein","volume":"20","author":"Hennequin","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.gofs.2020.12.010_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-015-0473-x","article-title":"Ductal carcinoma in situ: treatment update and current trends","volume":"17","author":"Mitchell","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.gofs.2020.12.010_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib10","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/ijc.30413","article-title":"Cause-specific mortality in women with breast cancer in situ","volume":"140","author":"He","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gofs.2020.12.010_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0140-6736(03)13859-7","article-title":"Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial","volume":"362","author":"Houghton","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2020.12.010_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.canrad.2016.04.004","article-title":"Breast-conserving treatment for ductal carcinoma in situ: impact of boost and tamoxifen on local recurrences","volume":"20","author":"Cutuli","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.gofs.2020.12.010_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17\u00a0and B-24\u00a0randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gofs.2020.12.010_bib14","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"Breast Cancer Cooperative Group EORTC","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/02841860600681569","article-title":"SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening","volume":"45","author":"Emdin","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib16","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20\u00a0years follow-up in the randomized SweDCIS Trial","volume":"32","author":"W\u00e4rnberg","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","article-title":"The influence of margin width on local control of ductal carcinoma in situ of the breast","volume":"340","author":"Silverstein","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2020.12.010_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clbc.2016.02.002","article-title":"Importance of surgical margin status in ductal carcinoma in situ","volume":"16","author":"Shaikh","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.gofs.2020.12.010_bib19","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.2008.17.5182","article-title":"Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ","volume":"27","author":"Dunne","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib20","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-016-5446-2","article-title":"The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis","volume":"23","author":"Marinovich","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib21","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.ijrobp.2012.10.020","article-title":"Outcomes in patients treated with mastectomy for ductal carcinoma in situ","volume":"85","author":"Owen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.gofs.2020.12.010_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jss.2018.05.007","article-title":"Treatment patterns for ductal carcinoma in situ with close or positive mastectomy margins","volume":"231","author":"Jones","year":"2018","journal-title":"J Surg Res"},{"key":"10.1016\/j.gofs.2020.12.010_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.critrevonc.2019.04.016","article-title":"The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: suggestions for routine practice","volume":"138","author":"Montero-Luis","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.gofs.2020.12.010_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2007.12.7969","article-title":"Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast","volume":"26","author":"Holmberg","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib26","first-page":"CD000563","article-title":"Postoperative radiotherapy for ductal carcinoma in situ of the breast","author":"Goodwin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2020.12.010_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/1754-9485.12428","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for ductal carcinoma in situ (DCIS) of the breast","volume":"60","author":"Oar","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2020.12.010_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gofs.2020.12.010_bib31","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-019-07537-y","article-title":"Comparison of local recurrence risk estimates after breast-conserving surgery for DCIS: DCIS nomogram versus refined oncotype DX breast DCIS score","volume":"26","author":"Van Zee","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib32","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gofs.2020.12.010_bib33","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1200\/JCO.2016.67.8532","article-title":"Cost effectiveness of the oncotype DX DCIS score for guiding treatment of patients with ductal carcinoma in situ","volume":"34","author":"Raldow","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib34","first-page":"109","article-title":"Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ","author":"Rakovitch","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gofs.2020.12.010_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1075-122X.2005.21617.x","article-title":"Defining negative margins in DCIS patients treated with breast conservation therapy: the University of Chicago experience","volume":"11","author":"Sahoo","year":"2005","journal-title":"Breast J"},{"key":"10.1016\/j.gofs.2020.12.010_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.sla.0000157272.04803.1b","article-title":"Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey","volume":"241","author":"Taghian","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.gofs.2020.12.010_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jso.1041","article-title":"Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy","volume":"76","author":"Vicini","year":"2001","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib38","article-title":"Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622\u00a0patients","author":"Cambra","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canrad.2015.01.002","article-title":"Ductal carcinoma in situ treated with radiation therapy and additional boost","volume":"19","author":"Geiss","year":"2015","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.gofs.2020.12.010_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2015.01.001","article-title":"The role of boost and hypofractionation as adjuvant radiotherapy in patients with DCIS: a meta-analysis of observational studies","volume":"114","author":"Nilsson","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijrobp.2018.09.022","article-title":"Local relapse after breast-conserving therapy versus mastectomy for extensive pure ductal carcinoma in situ\u22654\u00a0cm","volume":"103","author":"Hamilton","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.gofs.2020.12.010_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.breast.2018.07.007","article-title":"Breast-conserving therapy for primary ductal carcinoma in situ in The Netherlands: a multi-center study and population-based analysis","volume":"42","author":"Jobsen","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.gofs.2020.12.010_bib44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/jrr\/rrv034","article-title":"Final results from a multicenter prospective study (JROSG 05-5) on postoperative radiotherapy for patients with ductal carcinoma in situ with an involved surgical margin or close margin widths of 1mm or less","volume":"56","author":"Shikama","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.gofs.2020.12.010_bib45","article-title":"International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast","author":"Olivotto","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1470-2045(20)30085-1","article-title":"Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07\/TROG 07.01): 2-year results of a randomised, controlled, phase 3\u00a0trial","volume":"21","author":"King","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib47","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.canrad.2016.07.030","article-title":"Prevention of radio-induced cancers","volume":"20Suppl","author":"Cosset","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.gofs.2020.12.010_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.breast.2018.08.094","article-title":"Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194\u00a0study","volume":"42","author":"Ozkaya Akagunduz","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.gofs.2020.12.010_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.breast.2017.07.004","article-title":"Risk of secondary malignancies after radiation therapy for breast cancer: comprehensive results","volume":"35","author":"Burt","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.gofs.2020.12.010_bib50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijrobp.2015.07.2266","article-title":"Report on the clinical outcomes of permanent breast seed implant for early-stage breast cancers","volume":"93","author":"Pignol","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.gofs.2020.12.010_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2020.12.010_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00066-016-1066-9","article-title":"Accelerated partial breast irradiation with external beam radiotherapy: first results of the German phase 2\u00a0trial","volume":"193","author":"Ott","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.gofs.2020.12.010_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5114\/jcb.2018.73994","article-title":"Accelerated partial breast irradiation in a single 18Gy fraction with high-dose-rate brachytherapy: preliminary results","volume":"10","author":"Latorre","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.gofs.2020.12.010_bib54","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2020.12.010_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2018.12.030","article-title":"Ductal carcinoma in situ and intraoperative partial breast irradiation: who are the best candidates? Long-term outcome of a single institution series","volume":"133","author":"Leonardi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib56","article-title":"Long-term outcomes with 3-dimensional conformal external beam accelerated partial breast irradiation","author":"Kennedy","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0300891618811278","article-title":"External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3\u00a0randomized trial","volume":"105","author":"Becherini","year":"2019","journal-title":"Tumori"},{"key":"10.1016\/j.gofs.2020.12.010_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13014-019-1417-7","article-title":"3\u00a0fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen","volume":"14","author":"Mutter","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","volume":"18","author":"Polg\u00e1r","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gofs.2020.12.010_bib60","unstructured":"3D-CRT, Proton, or brachytherapy APBI in treating patients with invasive and non-invasive breast cancer\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03391388. (accessed October 26, 2020)."},{"key":"10.1016\/j.gofs.2020.12.010_bib61","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","article-title":"Accelerated partial breast irradiation consensus statement from the american society for radiation oncology (ASTRO)","volume":"74","author":"Smith","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.gofs.2020.12.010_bib62","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1245\/s10434-016-5449-z","article-title":"Society of Surgical Oncology\u2013American Society for Radiation Oncology\u2013American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"23","author":"Morrow","year":"2016","journal-title":"Ann Surg Oncol"},{"year":"2015","series-title":"Intraoperative radiotherapy for women with ductal carcinoma in situ breast cancer after nipple-sparing mastectomy. clinicaltrials.gov","author":"Ning","key":"10.1016\/j.gofs.2020.12.010_bib63"},{"year":"2020","series-title":"November (Novem- (9), BrEast Radiation), a phase II trial of a 9\u00a0day course of whole breast radiotherapy for early stage breast cancer. clinicaltrials.gov","author":"University of Utah","key":"10.1016\/j.gofs.2020.12.010_bib64"},{"key":"10.1016\/j.gofs.2020.12.010_bib65","unstructured":"BrUOG 351: preoperative APBI using NIBB\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03437915 (accessed October 26, 2020)."},{"year":"2020","series-title":"Locoregional breast cancer recurrence following targeted intraoperative radiotherapy (IORT) for ductal carcinoma in situ (DCIS). clinicaltrials.gov","author":"Connolly","key":"10.1016\/j.gofs.2020.12.010_bib66"},{"key":"10.1016\/j.gofs.2020.12.010_bib67","unstructured":"Management of low-risk DCIS\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02492607 (accessed October 26, 2020)."},{"key":"10.1016\/j.gofs.2020.12.010_bib68","unstructured":"Radiotherapy omission in low risk ductal in situ carcinoma breast\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03878342 (accessed October 26, 2020)."},{"year":"2020","series-title":"A randomized phase II study comparing surgical excision versus neoadjuvant radiotherapy followed by delayed surgical excision of ductal carcinoma in situ (NORDIS). clinicaltrials.gov","author":"Stanford University","key":"10.1016\/j.gofs.2020.12.010_bib69"},{"year":"2015","series-title":"Intraoperative radiotherapy after breast-conversing surgery in treating women with ductal carcinoma in situ breast cancer. clinicaltrials.gov","author":"Ning","key":"10.1016\/j.gofs.2020.12.010_bib70"},{"year":"2020","series-title":"A phase II study of real-time MRI-guided 3-fraction accelerated partial breast irradiation in early breast cancer (MAPBI). clinicaltrials.gov","author":"University of Wisconsin Madison","key":"10.1016\/j.gofs.2020.12.010_bib71"},{"key":"10.1016\/j.gofs.2020.12.010_bib72","unstructured":"An Efficacy Study of the Xoft\u00ae Axxent\u00ae eBx\u00ae IORT System\u00ae \u201cLite\u201d - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04349111 (accessed October 26, 2020)."},{"key":"10.1016\/j.gofs.2020.12.010_bib73","unstructured":"Comparing an operation to monitoring, with or without endocrine therapy (COMET) trial for low risk DCIS\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02926911 (accessed October 26, 2020)."},{"year":"2020","series-title":"Ultra-short external beam-based accelerated partial breast irradiation (APBI): a phase II toxicity study nested with a non-inferiority assessment of APBI in new patient cohorts. clinicaltrials.gov","author":"Memorial Sloan Kettering Cancer Center","key":"10.1016\/j.gofs.2020.12.010_bib74"},{"key":"10.1016\/j.gofs.2020.12.010_bib75","unstructured":"Hypofractionated partial breast irradiation in treating patients with early stage breast cancer\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03077841 (accessed October 26, 2020)."},{"key":"10.1016\/j.gofs.2020.12.010_bib76","unstructured":"Radiation therapy in treating patients with stage 0-II breast cancer\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01245712 (accessed October 26, 2020)."},{"key":"10.1016\/j.gofs.2020.12.010_bib77","unstructured":"Radiotherapy versus low-dose tamoxifen following breast conserving surgery for low-risk breast ductal carcinoma in situ\u00a0\u2013\u00a0full text view\u00a0\u2013\u00a0ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04046159 (accessed December 5, 2020)."},{"year":"2020","series-title":"A multicentric phase III trial evaluating the impact of a radiation boost (16Gy) after breast conserving surgery and a whole breast irradiation (50Gy) for DCIS. clinicaltrials.gov","author":"Institut du Cancer de Montpellier\u00a0\u2013\u00a0Val d\u2019Aurelle","key":"10.1016\/j.gofs.2020.12.010_bib78"},{"key":"10.1016\/j.gofs.2020.12.010_bib79","unstructured":"Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00470236 (accessed December 5, 2020)."}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920303925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920303925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:40:16Z","timestamp":1762854016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718920303925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2468718920303925"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2020.12.010","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survie globale et sans r\u00e9cidive locale en cas de radioth\u00e9rapie du lit tumoral des carcinomes canalaires in situ du sein\u00a0: revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}